Open AccessThe Role of D-Dimers in the Initial Evaluation of COVID-19
Author(s) -
Liliana Baroiu,
Ana Cristina Lese,
Ioana Anca Ștefanopol,
Alina Iancu,
Caterina Dumitru,
Anamaria Ciubară,
Florin Ciprian Bujoreanu,
Nicuşor Baroiu,
Anamaria Ciubară,
Alexandru Nechifor,
Lucreţia Anghel,
Alin Laurenţiu Tatu
Publication year - 2022
Publication title -
therapeutics and clinical risk management
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.719
H-Index - 55
eISSN - 1178-203X
pISSN - 1176-6336
DOI - 10.2147/tcrm.s357214
Subject(s) - medicine , asymptomatic , bilirubin , creatine kinase , creatinine , aspartate transaminase , gastroenterology , covid-19 , erythrocyte sedimentation rate , cardiology , alkaline phosphatase , biochemistry , chemistry , disease , infectious disease (medical specialty) , enzyme
The COVID-19 pandemic was noted for the high degree of contagion and the large number of cases, as well as for the various clinical forms, from asymptomatic towards rapid evolution to death. The hospitals limited care capacity imposed the need to identify some markers of unfavorable evolution. The purpose of our study is to identify the parameters correlated with COVID-19 unfavorable evolution and to draw the profile of the patient at risk of unfavorable evolution. This set of parameters will help the doctor in deciding whether to hospitalize a patient and in choosing the treatment.